Skip to main navigation Skip to search Skip to main content

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial (Nature Communications, (2026), 17, 1, (1538), 10.1038/s41467-026-68324-4)

  • Amanda L. Huff
  • , S. Daniel Haldar
  • , Alexander A. Girgis
  • , Hejia Henry Wang
  • , Ludmila Danilova
  • , Thatcher Heumann
  • , Maureen Berg
  • , Yuxuan Wang
  • , Lalitya Andaloori
  • , Alexei Hernandez
  • , Gabriella Longway
  • , Benjamin Barrett
  • , Zirui Zhu
  • , Emily Davis-Marcisak
  • , Christopher Thoburn
  • , James Leatherman
  • , Sarah Mitchell
  • , Jae W. Lee
  • , Daniel H. Shu
  • , Maximillian F. Konig
  • Brian J. Mog, Janelle Montagne, Erin M. Coyne, Katherine Bever, Marina Baretti, Mark Yarchoan, Robert A. Anders, Luciane T. Kagohara, Daniel Laheru, Amy M. Thomas, Jennifer Durham, Julie M. Nauroth, Jiayun Lu, Hao Wang, Elana J. Fertig, Won Jin Ho, Nilofer S. Azad, Elizabeth M. Jaffee, Neeha Zaidi

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-026-68324-4, published online 10 February 2026 In this article, the author’s name Alexander A. Girgis was incorrectly written as Alexander A. Gergis. The original article has been corrected.

Original languageEnglish (US)
Article number3516
JournalNature communications
Volume17
Issue number1
DOIs
StatePublished - Dec 2026

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial (Nature Communications, (2026), 17, 1, (1538), 10.1038/s41467-026-68324-4)'. Together they form a unique fingerprint.

Cite this